Bizjournals -- A.P. Pharma Inc. on Thursday reported a first quarter loss of $6.8 million, or 22 cents a share, compared with a loss of $6 million, or 94 cents a share in the same period last year which was computed on a smaller outstanding share base. The Redwood City-based specialty pharmaceutical company (NASDAQ:APPA) said the widened loss was principally due to increased research and development costs related to its undisclosed opiate product candidate for pain and greater personnel and related costs. Read full article below.
